LGC, a laboratory equipment supplier, agreed to acquire Technopath Clinical Diagnostics, a provider of solutions for clinical laboratories. Financial terms were not disclosed. "We are really excited to be bringing Technopath’s full-fledged chemistry and immunoassay controls into LGC. Their multi-constituent quality control products will dovetail perfectly with the calibration verification, molecular and serology product portfolios within our Clinical Diagnostics business unit. We look forward to combining Technopath’s and LGC’s expertise to deliver unrivalled solutions for our customers," Euan O’Sullivan, LGC President and COO.